Gilead Sciences, Inc.
Holdings as of Sep 30, 2026 · filed Nov 6, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Arcus Biosciences Inc. | $811701551 | 55.45% | — | Held |
| 2 | Lakefront Biotherapeutics | $501284604 | 34.24% | — | Held |
| 3 | Assembly Biosciences Inc. | $116911821 | 7.99% | — | Held |
| 4 | Kyverna Therapeutics Inc. | $28057609 | 1.92% | — | Held |
| 5 | Xilio Therapeutics Inc. | $5886020 | 0.40% | — | Held |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.